Aniline hydrochloride

• Catalog No.: 10414
• CAS Number: 142-04-1
• M. F.: C6H8ClN
• M. W.: 129.58742
• Purity: ≥99.0% (AT)

SYNONYMS

• Title: 苯胺 盐酸盐
• IUPAC name: aniline hydrochloride
• IUPAC Traditional name: aniline hydrochloride

DATABASE IDS

• PubChem SID: 24846637
• CAS Number: 142-04-1
• MDL Number: MFCD00012958
• EC Number: 205-519-8
• Beilstein Number: 3593823

PROPERTIES

• Antion Traces: sulfate (SO42-): ≤200 mg/kg
• Grade: purum p.a.
• Ignition Residue: ≤0.05%
• Linear Formula: C6H5NH2 · HCl
• Purity: ≥99.0% (AT)
• Flash Point: 194 °C
• Flash Point: 381.2 °F
• Melting Point: 196-198 °C(lit.)
• Melting Point: 197-200 °C
• Vapor Density: 4.46 (vs air)
• GHS Signal Word: Danger
• GHS Hazard statements: H301-H311-H317-H318-H331-H341-H351-H372-H400
• European Hazard Symbols: Toxic (T)
• European Hazard Symbols: Nature polluting (N)
• Personal Protective Equipment: Eyeshields, Faceshields, full-face particle respirator type N100 (US), Gloves, respirator cartridge type N100 (US), type P1 (EN143) respirator filter, type P3 (EN 143) respirator cartridges
• GHS Precautionary statements: P261-P273-P280-P301 + P310-P305 + P351 + P338-P311
• RID/ADR: UN 1548 6.1/PG 3
• Risk Statements: 23/24/25-40-41-43-48/23/24/25-50-68
• RTECS: CY0875000
• Safety Statements: 26-27-36/37/39-45-61-63
• Hazard Class: 6.1
• UN Number: 1548
• Packing Group: 3
• German water hazard class: 2

DETAILS

Description (English)

Biochem/physiol Actions
The acute toxicity of aniline involves its activation in vivo to 4-hydroxyaniline and the formation of adducts with hemoglobin. In erythrocytes, this is associated with the release of iron and the accumulation of methemoglobin and the development of hemolytic anemia and inflammation of the spleen. Tumor formation is often observed in the spleen on prolonged administration.

Description (简体中文)

Biochem/physiol Actions
The acute toxicity of aniline involves its activation in vivo to 4-hydroxyaniline and the formation of adducts with hemoglobin. In erythrocytes, this is associated with the release of iron and the accumulation of methemoglobin and the development of hemolytic anemia and inflammation of the spleen. Tumor formation is often observed in the spleen on prolonged administration.